We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bioqual Inc (PK) | USOTC:BIOQ | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 72.50 | 72.50 | 79.00 | 0.00 | 13:27:41 |
BIOQUAL:
2014
2013
Revenue $ 21,579,740 $ 20,204,308 (Loss) Income Before Income Tax $ 1,495,164 $ (107,016 ) Net (Loss) Income $ 868,201 $ (87,244 )Basic (Loss) Earnings per Share of Common Stock
$
.97
$
(.10
)
Diluted (Loss) Earnings per Share of Common Stock
$
.97
$
(.10
)
Weighted Average Number of Shares Outstanding For Basic Earnings
893,470 894,934Weighted Average Number of Shares Outstanding For Diluted Earnings
893,470 894,934BIOQUAL’s Board of Directors has declared a dividend of $0.20 per share for shareholders of record on November 28, 2014, payable on December 15, 2014. This is the thirteenth dividend declared by BIOQUAL.
Statements herein that are not descriptions of historical facts are forward-looking and subject to risk and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors including risks relating to the ability to continue to extend current government contracts and obtain new contracts; the actual cost incurred in performing its contracts; uncertainties relating to clinical trials; dependence on third parties; and future capital needs.
BIOQUALMark G. Lewis, Ph.D., CEO301-251-2801www.bioqual.com
1 Year Bioqual (PK) Chart |
1 Month Bioqual (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions